News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,495 Results
Type
Article (41717)
Company Profile (326)
Press Release (660452)
Section
Business (210078)
Career Advice (2069)
Deals (36566)
Drug Delivery (95)
Drug Development (82760)
Employer Resources (171)
FDA (16474)
Job Trends (15347)
News (355294)
Policy (33810)
Tag
Academia (2574)
Alliances (51032)
Alzheimer's disease (1230)
Approvals (16391)
Artificial intelligence (124)
Bankruptcy (362)
Best Places to Work (11592)
Biotechnology (210)
Breast cancer (103)
Cancer (909)
Career advice (1733)
Cell therapy (196)
Clinical research (65418)
Collaboration (324)
Compensation (159)
COVID-19 (2591)
Cystic fibrosis (80)
Data (837)
Diabetes (130)
Diagnostics (6175)
Drug pricing (85)
Earnings (85775)
Employer resources (149)
Events (111598)
Executive appointments (246)
FDA (16912)
Funding (290)
Gene therapy (156)
GLP-1 (588)
Government (4435)
Healthcare (18830)
Infectious disease (2664)
Inflammatory bowel disease (105)
Interviews (319)
IPO (16540)
Job creations (4049)
Job search strategy (1485)
Layoffs (427)
Legal (8311)
Lung cancer (156)
Manufacturing (157)
Medical device (13225)
Medtech (13230)
Mergers & acquisitions (20025)
Metabolic disorders (365)
Neuroscience (1477)
NextGen Class of 2024 (6618)
Non-profit (4510)
Northern California (1185)
Obesity (219)
Opinion (199)
Patents (97)
People (58062)
Pharmaceutical (92)
Phase I (20205)
Phase II (28776)
Phase III (21622)
Pipeline (204)
Postmarket research (2643)
Preclinical (8607)
Radiopharmaceuticals (239)
Rare diseases (188)
Real estate (6238)
Regulatory (22268)
Research institute (2356)
Resumes & cover letters (358)
Southern California (1069)
Startups (3710)
United States (11585)
Vaccines (552)
Weight loss (171)
Date
Last 7 days (783)
Last 30 days (2713)
Last 365 days (36122)
2024 (30593)
2023 (40628)
2022 (51797)
2021 (56331)
2020 (54795)
2019 (47400)
2018 (35771)
2017 (33139)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29730)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (193)
Asia (39870)
Australia (6370)
California (2689)
Canada (1169)
China (212)
Colorado (117)
Connecticut (120)
Europe (84824)
Florida (386)
Georgia (98)
Illinois (313)
Indiana (183)
Kansas (95)
Maryland (513)
Massachusetts (2204)
Michigan (143)
Minnesota (247)
New Jersey (819)
New York (828)
North Carolina (674)
Northern California (1185)
Ohio (123)
Pennsylvania (741)
South America (1157)
Southern California (1069)
Texas (381)
Washington State (322)
702,495 Results for "novabay pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay® Pharmaceuticals, Inc. and Eyenovia, Inc. have commenced activities under a previously announced co-promotion agreement.
July 1, 2024
·
8 min read
Policy
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
NovaBay® Pharmaceuticals, Inc. announces that the NYSE American LLC has accepted the Company’s plan to regain compliance with NYSE American’s continued listing standards.
June 7, 2024
·
4 min read
Press Releases
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
NovaBay Pharmaceuticals, Inc. announces it will be offering special promotions and discounts on its Avenova®-branded eyecare products to customers and eyecare professionals throughout July in support of National Dry Eye Awareness Month.
June 28, 2024
·
4 min read
Business
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2024 and provides a business update.
May 9, 2024
·
10 min read
Biotech Bay
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
NovaBay ® Pharmaceuticals, Inc. announces the introduction of an expanded line of Avenova ® product bundles specifically designed to provide easy, affordable and effective solutions for individualized relief from dry eye symptoms.
May 13, 2024
·
6 min read
Biotech Bay
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
NovaBay® Pharmaceuticals, Inc. announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003 and of the NYSE American Company Guide pursuant to stockholders equity.
April 19, 2024
·
3 min read
Biotech Bay
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase from the first quarter of 2023.
April 17, 2024
·
4 min read
Business
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
NovaBay® Pharmaceuticals, Inc. announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
May 3, 2024
·
2 min read
Biotech Bay
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
NovaBay® Pharmaceuticals, Inc. announces that a quorum was reached and that all proposals in the Company’s Definitive Proxy Statement filed on April 18, 2024 with the Securities and Exchange Commission were approved by stockholders at its 2024 Annual Meeting of Stockholders held on May 28, 2024.
May 29, 2024
·
8 min read
Business
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2023 and provides a business update.
March 26, 2024
·
12 min read
1 of 70,250
Next
